SEGMENT INFORMATION

9 Months Ended

Apr. 30, 2011

NOTE 17 - SEGMENT INFORMATION

The Company’s reportable segments, which are also its operating segments, consist of the Company’s Life Sciences and Industrial businesses.

As previously disclosed in the 2010 Form 10-K, the Company reorganized its operating segments during the fourth quarter of fiscal year 2010. Based on this reorganization, segment information for the three and nine months of fiscal year 2010 has been restated to reflect these changes. All discussions and amounts reported in this report are based on the reorganized segment structure.

The following table presents sales and operating profit by segment reconciled to earnings before income taxes, for the three and nine months ended April 30, 2011 and April 30, 2010.

	Three Months Ended				Nine Months Ended
	Apr. 30, 2011		Apr. 30, 2010		Apr. 30, 2011		Apr. 30, 2010
SALES:
Life Sciences	$	368,707	$	316,972	$	1,014,501	$	902,398
Industrial		341,101		299,010		946,016		820,924
Total	$	709,808	$	615,982	$	1,960,517	$	1,723,322

OPERATING PROFIT:
Life Sciences	$	89,071	$	73,415	$	245,909	$	206,329
Industrial		50,603		46,862		143,884		94,470
Total operating profit		139,674		120,277		389,793		300,799
General corporate expenses		16,454		13,034		45,755		38,631
Earnings before ROTC, interest expense,
net and income taxes		123,220		107,243		344,038		262,168
ROTC		7,723		2,030		13,921		6,659
Interest expense, net		6,068		3,254		19,176		6,342
Earnings before income taxes	$	109,429	$	101,959	$	310,941	$	249,167